Ibrance’s active ingredient is Palbociclib. Administered orally through capsules or tablets, it comes in three strengths: 75mg, 100mg, and 125mg.
Ibrance is a targeted therapy for this type of breast cancer, slowing and targeting the growth of cancer cells, which otherwise multiply uncontrollably.